Lapses in memory are a fairly normal part of healthy aging. But in the early stages of neurodegenerative diseases like Alzheimer’s dementia, cognitive changes…
Although it has long been known that women are more susceptible to Alzheimer’s than men – two-thirds of Americans with Alzheimer’s are women –…
TauRx is currently running a Phase 3 trial called LUCIDITY for what they hope will become the first ever Alzheimer’s pill. But they’ve had…
Like an aged book, DNA in the brain acquires wear and tear during your lifespan. Earlier this year, researchers from Brigham and Women’s Hospital…
A new study shows that individuals with a neurodegenerative language disorder called primary progressive aphasia (PPA) have Alzheimer’s-like plaques and tangles in their brains…
The busy life of brain cells is not so different from the supply chain that supports online purchases. A transaction is registered at a…
The Alzheimer’s research community has been working for decades to find an effective treatment for Alzheimer’s disease, largely by targeting one of the hallmarks…
While some scientists are focused on targeting beta-amyloid plaques to treat Alzheimer’s, others are honing in on another hallmark of the disease — pathological…
The toxic accumulation of four abnormal proteins in the brain is such a harbinger of cognitive decline, one researcher has taken to calling them…
Scanning technology is the most definitive way of diagnosing Alzheimer’s disease. One of the most accurate is called a positron emission tomography (PET) scan,…
Alzheimer’s Disease takes hundreds of thousands of lives every year, affecting 47 million people worldwide. But so far, no amount of urgency, nor billions…
Researchers in Florida have pinpointed a protein that contributes to Alzheimer’s biomarker tau protein accumulation in the brain. They argue it may be a…
Pulling an all-nighter or getting fewer hours of sleep than normal may have more consequences than simply suffering fatigue during the work day. According…
Much of Alzheimer’s research has focused on beta-amyloid plaques, one of the main drivers behind neurodegeneration in people with dementia. But more and more…
With repeated drug failures to treat Alzheimer’s disease in recent years, scientists are racing to find a vaccine to prevent the disease from evolving….